Posted On: 07/16/2014 9:54:22 AM
Post# of 9
BMTL Financials 07/16/2014 08:54:25
BioMedical Technology Solutions Holdings, Inc.
Period Ending Dec 31, 2010
Total Revenue 748
Cost of Revenue 392
Gross Profit 356
Operating Expenses
Research and Development 103
Sales, General and Admin. 1,399
Non-Recurring Items 304
Other -
Operating Income (1,450)
Income From Continuing Operations
Add'l Income/Expense Items -
Earnings Before Interest and Tax (1,450)
Interest Expense 49
Earnings Before Tax (1,499)
Income Tax -
Minority Interest -
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations (1,499)
Non Recurring Events
Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income (1,499)
Preferred Stock and Other Adjustments (4)
Net Income Applicable to Common Shareholders (1,503)
BioMedical Technology Solutions Holdings, Inc.
Period Ending Dec 31, 2010
Total Revenue 748
Cost of Revenue 392
Gross Profit 356
Operating Expenses
Research and Development 103
Sales, General and Admin. 1,399
Non-Recurring Items 304
Other -
Operating Income (1,450)
Income From Continuing Operations
Add'l Income/Expense Items -
Earnings Before Interest and Tax (1,450)
Interest Expense 49
Earnings Before Tax (1,499)
Income Tax -
Minority Interest -
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations (1,499)
Non Recurring Events
Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income (1,499)
Preferred Stock and Other Adjustments (4)
Net Income Applicable to Common Shareholders (1,503)
(0)
(0)
